58 related articles for article (PubMed ID: 8833323)
1. Homogeneous enzyme-based binding assay for studying glycosaminoglycan interactions with macromolecules and peptides.
Guo X; Han IS; Yang VC; Meyerhoff ME
Anal Biochem; 1996 Mar; 235(2):153-60. PubMed ID: 8833323
[TBL] [Abstract][Full Text] [Related]
2. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site.
Alberdi E; Hyde CC; Becerra SP
Biochemistry; 1998 Jul; 37(30):10643-52. PubMed ID: 9692954
[TBL] [Abstract][Full Text] [Related]
3. Raman spectroscopic investigation of peptide-glycosaminoglycan interactions.
Ishwar AR; Jeong KJ; Panitch A; Akkus O
Appl Spectrosc; 2009 Jun; 63(6):636-41. PubMed ID: 19531291
[TBL] [Abstract][Full Text] [Related]
4. A novel method for evaluation of carbohydrate-binding activity: enzyme-linked carbohydrate-binding assay (ELCBA).
Dolzhenko MI; Lepekhin EA; Berezin VA
Biochem Mol Biol Int; 1994 Sep; 34(2):261-71. PubMed ID: 7849636
[TBL] [Abstract][Full Text] [Related]
5. Xanthine oxidase binding to glycosaminoglycans: kinetics and superoxide dismutase interactions of immobilized xanthine oxidase-heparin complexes.
Radi R; Rubbo H; Bush K; Freeman BA
Arch Biochem Biophys; 1997 Mar; 339(1):125-35. PubMed ID: 9056242
[TBL] [Abstract][Full Text] [Related]
6. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins.
Hileman RE; Fromm JR; Weiler JM; Linhardt RJ
Bioessays; 1998 Feb; 20(2):156-67. PubMed ID: 9631661
[TBL] [Abstract][Full Text] [Related]
8. Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions.
Nikitovic D; Zafiropoulos A; Tzanakakis GN; Karamanos NK; Tsatsakis AM
Anticancer Res; 2005; 25(4):2851-6. PubMed ID: 16080537
[TBL] [Abstract][Full Text] [Related]
9. Binding of interferon gamma by glycosaminoglycans: a strategy for localization and/or inhibition of its activity.
Fernandez-Botran R; Yan J; Justus DE
Cytokine; 1999 May; 11(5):313-25. PubMed ID: 10328871
[TBL] [Abstract][Full Text] [Related]
10. Pattern and spacing of basic amino acids in heparin binding sites.
Fromm JR; Hileman RE; Caldwell EE; Weiler JM; Linhardt RJ
Arch Biochem Biophys; 1997 Jul; 343(1):92-100. PubMed ID: 9210650
[TBL] [Abstract][Full Text] [Related]
11. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D
Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054
[TBL] [Abstract][Full Text] [Related]
12. Carriers for enzymatic attachment of glycosaminoglycan chains to peptide.
Takagaki K; Ishido K; Kakizaki I; Iwafune M; Endo M
Biochem Biophys Res Commun; 2002 Apr; 293(1):220-4. PubMed ID: 12054587
[TBL] [Abstract][Full Text] [Related]
13. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
[TBL] [Abstract][Full Text] [Related]
14. Peptide-binding macromolecules in the blood of seriously ill or mentally retarded patients.
Goodfriend TL; Sindel M; Fyhrquist F; Hong R; Azen E; Stewart JM
J Lab Clin Med; 1976 Feb; 87(2):299-319. PubMed ID: 1455
[TBL] [Abstract][Full Text] [Related]
15. Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1.
Yu H; Tyrrell D; Cashel J; Guo NH; Vogel T; Sipes JM; Lam L; Fillit HM; Hartman J; Mendelovitz S; Panel A; Roberts DD
Arch Biochem Biophys; 2000 Feb; 374(1):13-23. PubMed ID: 10640391
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into biological roles of protein-glycosaminoglycan interactions.
Raman R; Sasisekharan V; Sasisekharan R
Chem Biol; 2005 Mar; 12(3):267-77. PubMed ID: 15797210
[TBL] [Abstract][Full Text] [Related]
17. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
18. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
Hallak LK; Collins PL; Knudson W; Peeples ME
Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycans bind factor Xa in a Ca2+-dependent fashion and modulate its catalytic activity.
O'Brien LA; Stafford AR; Fredenburgh JC; Weitz JI
Biochemistry; 2003 Nov; 42(44):13091-8. PubMed ID: 14596625
[TBL] [Abstract][Full Text] [Related]
20. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization.
Nikolovska-Coleska Z; Wang R; Fang X; Pan H; Tomita Y; Li P; Roller PP; Krajewski K; Saito NG; Stuckey JA; Wang S
Anal Biochem; 2004 Sep; 332(2):261-73. PubMed ID: 15325294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]